Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 2
2006 2
2007 2
2008 2
2009 2
2010 1
2012 1
2013 3
2014 3
2015 3
2017 2
2018 3
2019 3
2020 3
2021 3
2022 5
2023 4
2024 8
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial.
Truyens M, Lobatón T, Ferrante M, Bossuyt P, Vermeire S, Pouillon L, Dewint P, Cremer A, Peeters H, Lambrecht G, Louis E, Rahier JF, Dewit O, Muls V, Holvoet T, Vandermeulen L, Peeters A, Gonzales GB, Bos S, Laukens D, De Vos M. Truyens M, et al. Among authors: dewint p. Gastroenterology. 2022 Nov;163(5):1294-1305.e3. doi: 10.1053/j.gastro.2022.07.052. Epub 2022 Aug 6. Gastroenterology. 2022. PMID: 35940251 Free article. Clinical Trial.
Clinical consequences of computer-aided colorectal polyp detection.
Sinonquel P, Eelbode T, Pech O, De Wulf D, Dewint P, Neumann H, Antonelli G, Iacopini F, Tate D, Lemmers A, Pilonis ND, Kaminski MF, Roelandt P, Hassan C, Ingrid D, Maes F, Bisschops R. Sinonquel P, et al. Among authors: dewint p. Gut. 2024 Nov 11;73(12):1974-1983. doi: 10.1136/gutjnl-2024-331943. Gut. 2024. PMID: 38876773
Belgian consensus guideline on the management of anal fissures.
Roelandt P, Bislenghi G, Coremans G, De Looze D, Denis MA, De Schepper H, Dewint P, Geldof J, Gijsen I, Komen N, Ruymbeke H, Stijns J, Surmont M, Van de Putte D, Van den Broeck S, Van Geluwe B, Wyndaele J. Roelandt P, et al. Among authors: dewint p. Acta Gastroenterol Belg. 2024 Apr-Jun;87(2):304-321. doi: 10.51821/87.2.11787. Acta Gastroenterol Belg. 2024. PMID: 39210763 Free article. Review.
Secondary anal fissures: a pain in the a*.
Ruymbeke H, Geldof J, De Looze D, Denis MA, De Schepper H, Dewint P, Gijsen I, Surmont M, Wyndaele J, Roelandt P. Ruymbeke H, et al. Among authors: dewint p. Acta Gastroenterol Belg. 2023 Jan-Mar;86(1):58-67. doi: 10.51821/86.1.11310. Acta Gastroenterol Belg. 2023. PMID: 36842176 Free article. Review. No abstract available.
Small bowel endoscopy and Peutz-Jeghers syndrome.
Korsse SE, Dewint P, Kuipers EJ, van Leerdam ME. Korsse SE, et al. Among authors: dewint p. Best Pract Res Clin Gastroenterol. 2012 Jun;26(3):263-78. doi: 10.1016/j.bpg.2012.03.009. Best Pract Res Clin Gastroenterol. 2012. PMID: 22704569 Review.
Safety and efficacy of salvage endoscopic submucosal dissection for Barrett's neoplasia recurrence after radiofrequency ablation.
Mesureur L, Deprez PH, Bisschops R, Pouw RE, Weusten BLAM, Barret M, Dewint P, Tate D, Leclercq P, Seewald S, Barbaro F, Baldaque-Silva F, Omae M, Pioche M, Figueiredo Ferreira M, Bourke MJ, Haidry R, Snauwaert C, Eisendrath P, De Maertelaer V, Rosewick N, Devière J, Lemmers A. Mesureur L, et al. Among authors: dewint p. Endoscopy. 2024 Sep;56(9):653-662. doi: 10.1055/a-2307-6949. Epub 2024 Apr 16. Endoscopy. 2024. PMID: 38626891
49 results